Europa. Opioid agonist treatment – the current situation in Europe (European Drug Report 2023)
Europa. Opioid agonist treatment – the current situation in Europe (European Drug Report 2023)
Opioid users represent the largest group undergoing specialised drug treatment, mainly in the form of opioid agonist treatment. On this page, you can find the latest analysis of the provision of opioid agonist treatment in Europe, including key data on coverage, the number of people in treatment, pathways to treatment and more.
(…) The data available on the characteristics of those receiving opioid agonist treatment underline the long-term nature of opioid problems. The data also indicate that Europe’s cohort of those who have had problems with heroin is ageing. This is illustrated by the fact that over 60 % (60 500) of clients in opioid agonist treatment are now aged 40 or older, while less than 10 % are under 30 years old. (EMCDDA, Lissabon, 16.06.2023)
https://www.emcdda.europa.eu/publications/european-drug-report/2023/opioid-agonist-treatment_en